RTW Biotech hails Novartis acquisition of investee Avidity
RTW Biotech Opportunities Ltd on Monday noted that Swiss pharmaceutical major Novartis AG has definitively agreed to buy portfolio company Avidity Biosciences Inc.
RTW, a Guernsey-based...
Mon, 27/10/2025 - 11:41